JAMA Pediatr:新生儿服用益生菌可降低功能性肠胃病风险

2014-01-15 koo 生物360

周一发布的一份研究结果显示,向新生儿肠道引入益生菌似乎可以降低他们发生肠绞痛的几率。这是显示益生菌有助缓解肠绞痛的最新研究结果。该研究被认为是首次检验新生儿服用益生菌能否预防功能性肠胃病发生的研究,功能性肠胃病包括肠绞痛、返流和便秘。 肠绞痛被认为与消化问题有关,有时被解释为婴儿的肠易激综合征,往往伴随新生儿的长时间哭闹。这种状况一直是新生儿父母焦虑的原因,在没有针对性治疗药物的情况下,

周一发布的一份研究结果显示,向新生儿肠道引入益生菌似乎可以降低他们发生肠绞痛的几率。这是显示益生菌有助缓解肠绞痛的最新研究结果。该研究被认为是首次检验新生儿服用益生菌能否预防功能性肠胃病发生的研究,功能性肠胃病包括肠绞痛、返流和便秘。

肠绞痛被认为与消化问题有关,有时被解释为婴儿的肠易激综合征,往往伴随新生儿的长时间哭闹。这种状况一直是新生儿父母焦虑的原因,在没有针对性治疗药物的情况下,新生儿父母经常用尽所有办法来安抚婴儿。最近的一份研究发现,多达 20% 的婴儿在出生后的头三个月会遭受肠绞痛。【原文下载】

周一发布的研究显示,来自意大利巴里阿尔多•莫罗大学(Aldo Moro University)的科学家让 589 名健康婴儿的父母在他们孩子出生后的头三个月每日给孩子服用五滴包含罗伊氏乳杆菌的滴剂或者安慰剂。罗伊氏乳杆菌对健康的影响已经经过充分研究。

据该研究的主要作者阿尔多•莫罗大学儿科教授 Flavia Indrio 称,在头三个月,服用了益生菌的婴儿的哭闹时间大大减少,每天难以安抚的哭闹时间平均从 71 分钟降至 38 分钟,吐奶次数减少,同时肠蠕动增加,这意味着便秘情况减少。这份研究报告周一刊登在美国医学协会(American Medical Association)的期刊JAMA Pediatrics上。

此前的研究(包括 Indrio 的一项研究)已经发现,罗伊氏乳杆菌似乎有助于缓解肠绞痛,但还没有研究预防肠绞痛的方法。科学家和医学界还正在研究益生菌是否有助于治疗一系列疾病,包括过敏、高胆固醇和感冒。

对婴儿肠胃问题的早期干预可能不仅对婴儿的健康有好处,而且对他们长大后的健康也非常重要。研究发现,肠绞痛症状和长大后发生的其他胃肠疾病似乎有关联。截至目前人类对罗伊氏乳杆菌的研究还没有出现有关不良事件的报道。



休斯顿贝勒医学院(Baylor College of Medicine)儿科系教授 Bruno Chumpitazi 称,最新的研究做的非常好,结果令人鼓舞。该研究被认为是迄今为止人类对益生菌缓解肠绞痛进行的最大规模的研究, Chumpitazi 没有参与该研究但为研究报告撰写了一篇评论。他称,益生菌对健康的长期作用仍是未知的,还需要进行研究。

Indrio 说,罗伊氏乳杆菌菌群似乎降低了肠炎的发生率、改善了肠道运动并缓解了疼痛,但她和其他专家表示,还需要进行更多研究来了解益生菌在人体中到底做了什么。因德里奥计划继续追踪这些婴儿以便研究他们在长大后肠道易激综合症和肠胃紊乱的发生率。

早期干预甚至在婴儿期防止胃肠痛的发生可能会改变这些疾病的发展轨迹。Indrio 说,也许肠道和大脑会因此发生改变。

原文出处:
Flavia Indrio, Antonio Di Mauro, Giuseppe Riezzo, Elisa Civardi, Cristina Intini, Luigi Corvaglia, Elisa Ballardini, Massimo Bisceglia, Mauro Cinquetti, Emanuela Brazzoduro, Antonio Del Vecchio, Silvio Tafuri, , Ruggiero Francavilla. Prophylactic Use of a Probiotic in the Prevention of Colic, Regurgitation, and Functional ConstipationA. JAMA Pediatr. January 13, 2014; doi:10.1001/jamapediatrics.2013.4367【原文下载】

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1725568, encodeId=cc951e25568c4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 14 16:36:00 CST 2014, time=2014-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636796, encodeId=fffe1636e96e5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 15 01:36:00 CST 2014, time=2014-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075793, encodeId=cf2420e5793ab, content=<a href='/topic/show?id=d0278163120' target=_blank style='color:#2F92EE;'>#肠胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81631, encryptionId=d0278163120, topicName=肠胃病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Nov 03 04:36:00 CST 2014, time=2014-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915380, encodeId=a108191538082, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Tue Jul 08 06:36:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532478, encodeId=c17515324e850, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Fri Jan 17 08:36:00 CST 2014, time=2014-01-17, status=1, ipAttribution=)]
    2014-04-14 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1725568, encodeId=cc951e25568c4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 14 16:36:00 CST 2014, time=2014-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636796, encodeId=fffe1636e96e5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 15 01:36:00 CST 2014, time=2014-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075793, encodeId=cf2420e5793ab, content=<a href='/topic/show?id=d0278163120' target=_blank style='color:#2F92EE;'>#肠胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81631, encryptionId=d0278163120, topicName=肠胃病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Nov 03 04:36:00 CST 2014, time=2014-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915380, encodeId=a108191538082, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Tue Jul 08 06:36:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532478, encodeId=c17515324e850, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Fri Jan 17 08:36:00 CST 2014, time=2014-01-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1725568, encodeId=cc951e25568c4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 14 16:36:00 CST 2014, time=2014-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636796, encodeId=fffe1636e96e5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 15 01:36:00 CST 2014, time=2014-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075793, encodeId=cf2420e5793ab, content=<a href='/topic/show?id=d0278163120' target=_blank style='color:#2F92EE;'>#肠胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81631, encryptionId=d0278163120, topicName=肠胃病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Nov 03 04:36:00 CST 2014, time=2014-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915380, encodeId=a108191538082, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Tue Jul 08 06:36:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532478, encodeId=c17515324e850, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Fri Jan 17 08:36:00 CST 2014, time=2014-01-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1725568, encodeId=cc951e25568c4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 14 16:36:00 CST 2014, time=2014-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636796, encodeId=fffe1636e96e5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 15 01:36:00 CST 2014, time=2014-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075793, encodeId=cf2420e5793ab, content=<a href='/topic/show?id=d0278163120' target=_blank style='color:#2F92EE;'>#肠胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81631, encryptionId=d0278163120, topicName=肠胃病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Nov 03 04:36:00 CST 2014, time=2014-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915380, encodeId=a108191538082, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Tue Jul 08 06:36:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532478, encodeId=c17515324e850, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Fri Jan 17 08:36:00 CST 2014, time=2014-01-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1725568, encodeId=cc951e25568c4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 14 16:36:00 CST 2014, time=2014-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636796, encodeId=fffe1636e96e5, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 15 01:36:00 CST 2014, time=2014-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2075793, encodeId=cf2420e5793ab, content=<a href='/topic/show?id=d0278163120' target=_blank style='color:#2F92EE;'>#肠胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81631, encryptionId=d0278163120, topicName=肠胃病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Mon Nov 03 04:36:00 CST 2014, time=2014-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915380, encodeId=a108191538082, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Tue Jul 08 06:36:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532478, encodeId=c17515324e850, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Fri Jan 17 08:36:00 CST 2014, time=2014-01-17, status=1, ipAttribution=)]
    2014-01-17 xiaoshitou

相关资讯

J Pediatrics:研究者呼吁增加新生儿用药相关的药物临床试验

2012年10月27日--临床药物试验是制药企业新药通过FDA的重要步骤,近日,刊登在国际杂志The Journal of Pediatrics上的一篇研究报告评估了儿童及初生婴儿的用药相关临床试验的缺少、以及制药商和研究者如何共同努力开发新的试验方法来使得儿童、初生婴儿的用药更加有效、安全。 来自辛辛那提儿童医院医疗中心以及辛辛那提大学的研究者认为,初生婴儿临床用药试验的缺少是由许多因素引起的

美医院工作人员患结核病 数百新生儿或受影响

据美国中文网10月31日报道,美国曼哈顿圣卢克·罗斯福医院(St. Luke’s-Roosevelt Hospital)产科一名工作人员被查出结核阳性,数百名新生婴儿可能受影响。该医院30日已经对有关父母发出通知,并向市卫生局立即报告对那名工作人员的检查结果。 该医院表示正在采取措施解决问题,近日就医的病人如果没有接到医院的通知,则说明没有和受感染的工作人员接触过。最

喂奶方式不当致新生儿窒息死亡

  近日,泰安市儿童医院新生儿科紧急转入一名出生仅5小时的新生儿,护士在查房时发现婴儿的皮肤苍白、四肢松软,呼吸心跳微弱。经过紧急抢救,婴儿的生命被挽救回来。据医生判断,婴儿的发病可能是家长经验不足、护理不当所致。   护士查房发现婴儿状态异常   涛涛(化名)出生于4月25日,出生时3.3kg,出生后和正常的孩子一样,涛涛的到来让一家人兴奋不已。   因为是剖宫产,涛涛的母亲需要待在产房观

AJP:新生儿体重异常增自闭症风险

       英国曼彻斯特大学的一项新研究称,新生儿体重过轻或过重,都会对其未来健康成长造成影响,他们患自闭症谱系障碍(ASD)的风险明显要高于体重正常的新生儿。        曼彻斯特大学研究人员对40000多名瑞典儿童的健康记录进行分析后得出上述结论,并将其发表在《美国精神病学杂志》上。  

易致新生儿脑膜炎新菌首次被发现

记者从济南市疾控中心获悉,该中心从全市生活饮用水和临床样本中,分离出45株阪崎肠杆菌,其中36株为新的MLST分子型别,为世界首次发现。 据悉,阪崎肠杆菌为周生鞭毛的无芽孢革兰阴性菌属,以前被认为是阴沟肠杆菌。20世纪80年代以后,因为发现其可以引起新生儿脑膜炎、坏死性结肠炎和菌血症,甚至导致死亡或伴随严重的神经系统后遗症、发育障碍,因而受到广泛重视。 济南市疾控中心在阪崎肠杆菌监测及

NEJM:一种与新生儿发绀和贫血相关的血红蛋白变异体

    A Hemoglobin Variant Associated with Neonatal Cyanosis and Anemia   莫伊拉·A·克罗利等 美国俄亥俄州克利夫兰市凯斯西储大学新生儿科   提要   珠蛋白基因突变是发绀